Psoriatic Arthritis
News
Psoriatic arthritis associated with heavy drinking
Conference Coverage
Apremilast meets psoriasis endpoints at week 32
Key clinical point: Oral apremilast beat placebo and showed durable efficacy in patients with moderate to severe plaque psoriasis. Major finding:...
Conference Coverage
Ixekizumab met psoriasis endpoints by week 12, with durable response at 60 weeks
Key clinical point: The investigational anti-IL-17A antibody ixekizumab met its endpoints at week 12 in patients with plaque psoriasis, and showed...
Conference Coverage
IL-23 inhibitor topped ustekinumab against psoriasis
Key clinical point: The interleukin-23 inhibitor BI 655066 outperformed ustekinumab and generated no concerning safety signals in a small phase II...
News
Traditional risk factors raise cardiovascular risk in PsA
Key clinical point: The increased risk of cardiovascular disease in psoriatic arthritis is largely because of an increased prevalence of...
News
No increased risk of lung disease with methotrexate
Key clinical point: Methotrexate is not associated with an increased risk of pulmonary disease. Major finding: There was no increased risk of...
News
Rheumatologists support biosimilars, with caveats
News
Methotrexate and biologics linked to higher zoster risk in psoriasis
Key clinical point: The combination of methotrexate and biologics for the treatment of psoriasis may increase the risk of herpes zoster infection...
Conference Coverage
Secukinumab beat ustekinumab for psoriasis, with difference by week four
Key clinical point:Secukinumab achieved significantly better responses than ustekinumab in the treatment of moderate to severe psoriasis. Major...
Conference Coverage
Brodalumab achieved primary endpoints for moderate to severe psoriasis at 52 weeks
Key clinical point: At 52 weeks, brodalumab met its PASI 100 endpoint compared with ustekinumab in the pivotal phase III AMAGINE-2 trial. Major...
News
Halting biologics before surgery tied to flares in psoriasis, psoriatic arthritis
Key clinical point: Interrupting biologic therapy before surgery led to flares in psoriasis and psoriatic arthritis. Major finding: Discontinuing...